Ardelyx, Inc. (ARDX) — Stock Score Summary

Ardelyx, Inc. (ARDX) has a MoatMap StockRank of 44/100 based on Quality (41/100), Value (35/100), and Momentum (55/100) factor scores. The current signal is HOLD. A biopharmaceutical company focused on cardiorenal and gastrointestinal diseases that lacks the CDMO manufacturing moat or alignment with our core macro themes.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class targeted therapies for gastrointestinal and cardiorenal diseases. The company's competitive moat is anchored by its proprietary drug discovery platform, which has yielded unique mechanism-of-action treatments such as Ibsrela for IBS-C and Xphozah for hyperphosphatemia. By addressing significant unmet medical needs with patented, novel small molecules, Ardelyx is establishing a strong foothold in specialized therapeutic markets.

Key Financial Metrics

Price$5.60
Market Cap$1.5B
P/E (Forward)10.48
Price/Book8.97
Return on Equity-39.5%
Return on Invested Capital-7.8%
Debt/Equity157.53
Gross Margin74.6%
Operating Margin-34.7%
Revenue Growth27.5%
Free Cash Flow$86K

Ardelyx, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Ardelyx, Inc.’s (ARDX) StockRank?
MoatMap’s StockRank for Ardelyx, Inc. (ARDX) is 44/100, with a Hold signal. It is a composite of Quality (41), Value (35), and Momentum (55) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ardelyx, Inc. have an economic moat?
Ardelyx, Inc. (ARDX) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ardelyx, Inc. a buy, hold, or sell?
MoatMap’s current signal for Ardelyx, Inc. (ARDX) is Hold, based on a StockRank of 44/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ardelyx, Inc. in?
Ardelyx, Inc. (ARDX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksARDX deep dive reportAI ChampionsHow we score stocksSense-check another stock